4//SEC Filing
Hoffman Robert E. 4
Accession 0000905718-22-000393
CIK 0001498382other
Filed
Feb 16, 7:00 PM ET
Accepted
Feb 17, 4:00 PM ET
Size
5.4 KB
Accession
0000905718-22-000393
Insider Transaction Report
Form 4
HOFFMAN ROBERT
Director
Transactions
- Purchase
Common Stock
2022-02-15$0.47/sh+55,000$25,795→ 55,000 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.4625 to $0.4697 per share, inclusive. The reporting person undertakes to provide to Kintara Therapeutics, Inc., any security holder of Kintara Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth herein.
Documents
Issuer
Kintara Therapeutics, Inc.
CIK 0001498382
Entity typeother
Related Parties
1- filerCIK 0001166288
Filing Metadata
- Form type
- 4
- Filed
- Feb 16, 7:00 PM ET
- Accepted
- Feb 17, 4:00 PM ET
- Size
- 5.4 KB